3/18
11:03 pm
nvcr
NovoCure Limited (NASDAQ: NVCR) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
Low
Report
NovoCure Limited (NASDAQ: NVCR) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
3/4
07:00 am
nvcr
Novocure to Participate in Leerink Partners 2025 Global Healthcare Conference
Low
Report
Novocure to Participate in Leerink Partners 2025 Global Healthcare Conference
3/3
11:03 pm
nvcr
NovoCure Limited (NASDAQ: NVCR) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Low
Report
NovoCure Limited (NASDAQ: NVCR) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
2/28
05:20 am
nvcr
https://seekingalpha.com/article/4763298-novocures-expansion-strategy-struggles-to-translate-approvals-into-growth [Seeking Alpha]
Low
Report
https://seekingalpha.com/article/4763298-novocures-expansion-strategy-struggles-to-translate-approvals-into-growth [Seeking Alpha]
2/28
03:14 am
nvcr
NovoCure Ltd (NVCR) Q4 2024 Earnings Call Highlights: Strong Revenue Growth Amidst Financial ... [Yahoo! Finance]
Low
Report
NovoCure Ltd (NVCR) Q4 2024 Earnings Call Highlights: Strong Revenue Growth Amidst Financial ... [Yahoo! Finance]
2/27
12:46 pm
nvcr
NovoCure (NVCR) Reports Q4 Earnings: What Key Metrics Have to Say [Yahoo! Finance]
Low
Report
NovoCure (NVCR) Reports Q4 Earnings: What Key Metrics Have to Say [Yahoo! Finance]
2/27
10:10 am
nvcr
NovoCure (NVCR) Reports Q4 Loss, Misses Revenue Estimates [Yahoo! Finance]
Medium
Report
NovoCure (NVCR) Reports Q4 Loss, Misses Revenue Estimates [Yahoo! Finance]
2/27
07:00 am
nvcr
Novocure Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Company Update
High
Report
Novocure Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Company Update
1/22
04:00 am
nvcr
Novocure Inaugurates New Global Headquarters in Canton of Zug, Switzerland
Low
Report
Novocure Inaugurates New Global Headquarters in Canton of Zug, Switzerland
1/14
08:02 am
nvcr
NovoCure Limited (NASDAQ: NVCR) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $38.00 price target on the stock.
Low
Report
NovoCure Limited (NASDAQ: NVCR) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $38.00 price target on the stock.
1/13
08:11 pm
nvcr
NovoCure Limited (NASDAQ: NVCR) had its "neutral" rating re-affirmed by analysts at Wedbush. They now have a $29.00 price target on the stock.
Medium
Report
NovoCure Limited (NASDAQ: NVCR) had its "neutral" rating re-affirmed by analysts at Wedbush. They now have a $29.00 price target on the stock.
1/13
07:00 am
nvcr
Novocure Announces Preliminary Full Year and Fourth Quarter 2024 Performance and Provides Company Update
Low
Report
Novocure Announces Preliminary Full Year and Fourth Quarter 2024 Performance and Provides Company Update
1/3
07:00 am
nvcr
Novocure to Participate in 43rd Annual J.P. Morgan Healthcare Conference
Low
Report
Novocure to Participate in 43rd Annual J.P. Morgan Healthcare Conference